Donald Trump to announce plan to stop cash flow to Cuban military

Agencies
June 16, 2017

Washington, Jun 16: Stopping short of a complete turnabout, President Donald Trump is expected Friday to announce a revised Cuba policy aimed at stopping the flow of US cash to the country’s military and security services while maintaining diplomatic relations and allowing U.S. airlines and cruise ships to continue service to the island.

Cubany

In a speech Friday at a Miami theater associated with Cuban exiles, Trump will cast the policy moves as fulfillment of a promise he made during last year’s presidential campaign to reverse then-President Barack Obama’s diplomatic re-engagement with the island after decades of estrangement.

Senior White House officials who briefed reporters Thursday on the coming announcement said Obama’s overtures had enriched Cuba’s military while repression increased on the island. The officials spoke on condition of anonymity to discuss the policy before Trump announces it, despite the president’s regular criticism of the use of anonymous sources.

The moves to be announced by Trump are only a partial reversal of Obama’s policies, however. And they will saddle the U.S. government with the complicated task of policing U.S. travel to Cuba to make sure there are no transactions with the military-linked conglomerate that runs much of the Cuban economy.

By restricting individual U.S. travel to Cuba, the new policy also risks cutting off a major source of income for Cuba’s private business sector, which the policy is meant to support.

Under the expected changes, the U.S. will ban American financial transactions with the dozens of enterprises run by the military-linked corporation GAESA, which operates dozens of hotels, tour buses, restaurants and other facilities.

Most U.S. travelers to Cuba will again be required to visit the island as part of organized tour groups run by American companies. The rules also require a daylong schedule of activities designed to expose the travelers to ordinary Cubans. But because Cuban rules requires tour groups to have government guides and use state-run tour buses, the requirement has given the Cuban government near-total control of travelers’ itineraries and funneled much of their spending to state enterprises.

Obama eliminated the tour requirement, allowing tens of thousands of Americans to book solo trips and spend their money with individual bed-and-breakfast owners, restaurants and taxi drivers.

The U.S. Embassy in Havana, which reopened in August 2015, will remain as a full-fledged diplomatic outpost. Trump isn’t overturning Obama’s decision to end the “wet foot, dry foot” policy that allowed most Cuban migrants who made it onto U.S. soil to stay and eventually become legal permanent residents.

Also not expected are any changes to U.S. regulations governing what items Americans can bring back from Cuba, including the rum and cigars produced by state-run enterprises.

More details about the changes are expected to be released Friday, when the new policy is set to take effect. But none of the changes will become effective until the Treasury Department issues new regulations, which could take months. That means that any U.S. traveler currently booked on a flight to Cuba in the next few weeks, or even months, could go ahead and make the trip.

Critics said the changes would only hurt everyday Cubans who work in the private sector and depend on American visitors to help provide for their families. Supporters expressed appreciation for Trump’s emphasis on human rights in Cuba.

Obama announced in December 2014 that he and Cuban leader Raul Castro were restoring diplomatic ties between their countries, arguing that the policy the U.S. had pursued for decades had failed to bring about change and that it was time to try a new approach.

The U.S. severed diplomatic relations with Cuba in 1961 after Fidel Castro’s revolution. It spent subsequent decades trying to either overthrow the Cuban government or isolate the island, including toughening an economic embargo first imposed by President Dwight D. Eisenhower. The embargo remains in place and unchanged by Trump’s policy. Only the U.S. Congress can lift the embargo, and lawmakers, especially those of Cuban heritage, like Sen. Marco Rubio, R-Fla., have shown no interest in doing so.

The son of a Cuban immigrant, Rubio opposed Obama’s re-engagement with Cuba, saying Obama was making concessions to an “odious regime.”

Trump aides said Thursday that Rubio was “very helpful” to the administration as it spent months reviewing the policy. The senator, who challenged Trump for the Republican presidential nomination, was expected to travel with the president aboard Air Force One and appear with him at Friday’s announcement.

The change in the U.S. posture toward Cuba under Trump marks the latest policy about-face by the president.

While campaigning last year in Miami, which is home to a large Cuban-American population, Trump pledged to reverse Obama’s efforts to normalize relations with Cuba unless it met certain “demands,” including granting Cubans religious and political freedom, and releasing all political prisoners. He said he would “stand with the Cuban people in their fight against communist oppression,” and went on to win about half the Cuban vote in Florida in the presidential election.

Trump had previously said he supported restoring diplomatic relations but wished the U.S. had negotiated a better deal.

For the announcement, the White House chose to have Trump speak at the Manuel Artime Theate in Miami. The theater is named for an exile leader of the Bay of Pigs veterans’ association that endorsed Trump last October.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 7,2020

Moscow, Aug 7: Russia will register its first vaccine against the coronavirus on August 12, Deputy Health Minister Oleg Gridnev said on Friday.

The vaccine has been developed jointly by the Gamaleya Research Institute and the Russian Defence Ministry.

"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trials are extremely important. We have to understand that the vaccine must be safe. Medical professionals and senior citizens will be the first to get vaccinated," Gridnev told reporters at the opening of a cancer centre building in the city of Ufa.

According to the minister, the effectiveness of the vaccine will be judged when the population immunity has formed.

Clinical trials of the vaccine began on June 18 and included 38 volunteers. All of the participants developed immunity. 

The first group was discharged on July 15 and the second group on July 20.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 12,2020

Washington, Apr 12: The US has overtaken Italy as the country with the highest number of deaths due to COVID-19 pandemic with the fatalities crossing 20,000, according to Johns Hopkins University data, as the novel coronavirus continues to wreak havoc across the globe.

The deadly coronavirus, that originated in China in December last year, has so far killed more than one lakh people across the globe. The United States on Saturday became the country with the highest number of deaths at 20,597, surpassing Italy's 19,468 fatalities.

More than 5.3 lakh Americans have tested positive for coronavirus, which is about the same for the next four countries put together: Spain (163,027), Italy (152,271), Germany (125,452) and France (93,790). In terms of fatalities, the US and Italy are followed by Spain (16,606), France (13832) and United Kingdom (9,875), the varsity data showed.

New York City, the financial capital of the world, has emerged as the epicenter of coronavirus in the world. A city of 8.3 million, which is one of the most densely populated cities in the US, by Saturday night had as many as 8,627 deaths and more than 180,000 people had tested positive for COVID-19.

President Donald Trump has declared a national emergency and all the 50 States have been notified with major disaster declaration. More than 95 per cent of the country's 330 million population are under stay-at-home order. Trump has deployed more than 50,000 personnel from the armed forces in fight against COVID-19.

After an initial two-week social mitigation measures, that includes social distancing, the measures have been extended till April 30. Initially, members of the White House Task Force on Coronavirus had projected between one and two lakhs deaths. Now, they have dropped the projection to 60,000 deaths, mainly due to the successful implementation of these measures.

"The people of our country have gone through a lot. But we did it the right way. And we look like we'll be coming in on the very, very low side, really below the lowest, the lowest side of the curve of death," Trump told Fox News on Saturday night.

Trump asserted that situation was improving in places like New York, where there is a drop in new patients. Responding to a question, he said he wanted the country to open up as soon as possible.

However, he has not taken a decision so far, even as some media reports said that he the President was looking for early May.

"I think it's going to be the toughest decision that I've ever made. I really, hopefully that I ever will have to make. But it's certainly the toughest decision that I've ever made. I hope that I'm going to make the right decision," Trump said, adding that he will be making a decision reasonably soon.

"We're setting up a council now of some of the most distinguished leaders in virtually every field including politics and business and medical. We'll be making that decision fairly soon," Trump said.

Meanwhile, The New York Times reported that its investigations have revealed that the president was warned about a potential pandemic but that internal divisions, lack of planning and his faith in his own instincts led to a halting response.

According to The Washington Post, coronavirus is killing about one in 10 hospitalised middle-aged patients and four in 10 older than 85 in the United States. It is particularly lethal to men even when taking into account common chronic diseases that exacerbate risk.

Globally, the novel coronavirus has killed 108,862 people and infected over 1.7 million people globally. The US has the highest number of infections at 529,887, according to Johns Hopkins University data.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.